Applied Stemcell
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
521 Cottonwood Dr Ste 111, Milpitas, Cal...Phone Number
(408) 773-8007Website
www.appliedstemcell.comRevenue
$66.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Applied Stemcell
As a leading cell and gene therapy CRO/CDMO, Applied StemCell is a proud supporter of gene editing and stem cell therapy development. With two high-impact platforms, CRISPR/TARGATT Genome Editing and iPSC (GMP grade), we seek to help advance the development of novel therapeutics.Explore more
Applied Stemcell Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Applied Stemcell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Applied Stemcell, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Applied Stemcell has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Applied Stemcell is spiking on competitors!
Product Launch: Get notified when Applied Stemcell launches new products
Funding: Get notified immidiatlly once Applied Stemcell has new funding data
Earning: See what the market has to say on Applied Stemcell recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Applied Stemcell
Website visits: Recent activity has been detected on your website
Click to see if Applied Stemcell had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Applied Stemcell
Compare insights from companies similar to Applied Stemcell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Applied Stemcell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Applied Stemcell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Applied Stemcell.
Applied Stemcell financials insights
Gather financial insights about Applied Stemcell, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series B
$1.9M
2013
Series C
$2.6M
2016
Series D
$19M
2020
Debt
$1M
2021
Debt
$500K
Applied Stemcell Tech Stack
A closer look at the technologies used by Applied Stemcell
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Lateral Move
Executive Move
Executive Moves, Lateral Move
New Hire
Executive Move
Executive Moves, New Hire
Event
Product Marketing, Events, Research & Development, Bioengineering, Medical Research, Clinical Operations, Healthcare Technology
Event
Events, Medical Research, Clinical Operations, Healthcare Technology, Operations
Applied Stemcell News & Media
Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology
Applied StemCell uses TARGATT™ tech to insert a 50 kb multifunctional DNA construct into hiPSCs, enabling development of allogeneic iPSC-based therapies.Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer - Yahoo Finance
Dolores Baksh, Ph.D. Applied StemCell welcomes Dolores Baksh, Ph.D., as new CEO. MILPITAS, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Applied StemCell, a genome engineering product and services company, announced today the appointment of Dolores Baksh, Ph.D., as Chief Executive Officer. Company founder and former CEO Ruby Tsai, Ph.D., will continue to guide scientific strategy, innovation, and strategic collaborations as President and Chief Scientific Officer (CSO). “Dolores brings exactly the kiApplied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research
Applied StemCell launches hiEX™ Research iPSC Exosomes, designed as a scalable and consistent source of exosomes for regenerative medicine research.Applied StemCell Launches Two New Hypoimmunogenic hiPSC Products to Accelerate Allogeneic Cell Therapy Development
MILPITAS, Calif.--(BUSINESS WIRE)-- #AppliedStemCell--Applied StemCell announces the launch of two hypoimmunogenic hiPSC products to enable development of the next generation of allogeneic cell therapies.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Applied Stemcell
Sign Up For FreeTo access detailed company insights
As a leading cell and gene therapy CRO/CDMO, Applied StemCell is a proud supporter of gene editing and stem cell therapy development. With two high-impact platforms, CRISPR/TARGATT Genome Editing and iPSC (GMP grade), we seek to help advance the development of novel therapeutics.... Read More
